98 related articles for article (PubMed ID: 17709096)
1. Impact of diabetic serum on endothelial cells: an in-vitro-analysis of endothelial dysfunction in diabetes mellitus type 2.
Münzel D; Lehle K; Haubner F; Schmid C; Birnbaum DE; Preuner JG
Biochem Biophys Res Commun; 2007 Oct; 362(2):238-44. PubMed ID: 17709096
[TBL] [Abstract][Full Text] [Related]
2. Development of a disease-specific model to evaluate endothelial dysfunction in patients with diabetes mellitus.
Lehle K; Haubner F; Münzel D; Birnbaum DE; Preuner JG
Biochem Biophys Res Commun; 2007 May; 357(1):308-13. PubMed ID: 17418093
[TBL] [Abstract][Full Text] [Related]
3. Hyperglycemia increases the levels of vascular cellular adhesion molecule-1 and monocyte-chemoattractant-protein-1 in the diabetic endothelial cell.
Haubner F; Lehle K; Münzel D; Schmid C; Birnbaum DE; Preuner JG
Biochem Biophys Res Commun; 2007 Aug; 360(3):560-5. PubMed ID: 17618604
[TBL] [Abstract][Full Text] [Related]
4. Correlation between circulating adhesion molecule levels and albuminuria in type 2 diabetic normotensive patients.
Rubio-Guerra AF; Vargas-Robles H; Ayala GV; Escalante-Acosta BA
Med Sci Monit; 2007 Aug; 13(8):CR349-52. PubMed ID: 17660723
[TBL] [Abstract][Full Text] [Related]
5. Lycopus lucidus inhibits high glucose-induced vascular inflammation in human umbilical vein endothelial cells.
Lee YJ; Kang DG; Kim JS; Lee HS
Vascul Pharmacol; 2008 Jan; 48(1):38-46. PubMed ID: 18083068
[TBL] [Abstract][Full Text] [Related]
6. Increased soluble E-selectin levels in type 2 diabetic patients with peripheral arterial disease.
Boulbou MS; Koukoulis GN; Vasiou KG; Petinaki EA; Gourgoulianis KI; Fezoulidis IB
Int Angiol; 2004 Mar; 23(1):18-24. PubMed ID: 15156125
[TBL] [Abstract][Full Text] [Related]
7. Increased urinary orosomucoid excretion: a proposed marker for inflammation and endothelial dysfunction in patients with type 2 diabetes.
Christiansen MS; Iversen K; Larsen CT; Goetze JP; Hommel E; Mølvig J; Pedersen BK; Magid E; Feldt-Rasmussen B
Scand J Clin Lab Invest; 2009; 69(2):272-81. PubMed ID: 18972260
[TBL] [Abstract][Full Text] [Related]
8. Effect of a diet and exercise intervention on oxidative stress, inflammation and monocyte adhesion in diabetic men.
Roberts CK; Won D; Pruthi S; Lin SS; Barnard RJ
Diabetes Res Clin Pract; 2006 Sep; 73(3):249-59. PubMed ID: 16616795
[TBL] [Abstract][Full Text] [Related]
9. [Levels of soluble adhesion molecules among normal and hypertensive type 2 diabetic patients].
Rubio-Guerra AF; Vargas-Robles H; Medina-Santillán R; Escalante-Acosta BA
Gac Med Mex; 2008; 144(1):11-4. PubMed ID: 18619052
[TBL] [Abstract][Full Text] [Related]
10. Assessment of oxidative stress and endothelial dysfunction in Asian Indians with type 2 diabetes mellitus with and without macroangiopathy.
Singhania N; Puri D; Madhu SV; Sharma SB
QJM; 2008 Jun; 101(6):449-55. PubMed ID: 18385148
[TBL] [Abstract][Full Text] [Related]
11. Immunogenic properties of renal cell carcinoma and the pathogenesis of osteolytic bone metastases.
Perut F; Cenni E; Unger RE; Kirkpatrick CJ; Giunti A; Baldini N
Int J Oncol; 2009 May; 34(5):1387-93. PubMed ID: 19360351
[TBL] [Abstract][Full Text] [Related]
12. Protective role of adiponectin on endothelial dysfunction induced by AGEs: a clinical and experimental approach.
Del Turco S; Navarra T; Gastaldelli A; Basta G
Microvasc Res; 2011 Jul; 82(1):73-6. PubMed ID: 21397613
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil surface expression of CD11b and CD62L in diabetic microangiopathy.
Mastej K; Adamiec R
Acta Diabetol; 2008 Sep; 45(3):183-90. PubMed ID: 18496641
[TBL] [Abstract][Full Text] [Related]
14. Increased plasma and endothelial cell expression of chemokines and adhesion molecules in chronic kidney disease.
Stinghen AE; Gonçalves SM; Martines EG; Nakao LS; Riella MC; Aita CA; Pecoits-Filho R
Nephron Clin Pract; 2009; 111(2):c117-26. PubMed ID: 19147993
[TBL] [Abstract][Full Text] [Related]
15. In vitro angiomodulatory activity of sera from type 2 diabetic patients with background retinopathy.
Chorostowska-Wynimko J; Skopiński P; Szaflik J; Partyka I; Duda-Król B; Anuszewska E; Skopińska-Rózewska E
J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():65-70. PubMed ID: 16204777
[TBL] [Abstract][Full Text] [Related]
16. Soluble ICAM-1 and VCAM-1 as markers of endothelial activation.
Videm V; Albrigtsen M
Scand J Immunol; 2008 May; 67(5):523-31. PubMed ID: 18363595
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell dysfunction after coronary artery bypass grafting with extracorporeal circulation in patients with type 2 diabetes mellitus.
Lehle K; Preuner JG; Vogt A; Rupprecht L; Keyser A; Kobuch R; Schmid C; Birnbaum DE
Eur J Cardiothorac Surg; 2007 Oct; 32(4):611-6. PubMed ID: 17681783
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-7 is associated with monocyte chemoattractant protein-1 and soluble E-selectin levels in peripheral blood of newly post-menopausal women.
Yasui T; Saijo A; Uemura H; Tsuchiya N; Yuzurihara M; Kase Y; Irahara M
J Reprod Immunol; 2009 Jul; 81(1):97-102. PubMed ID: 19501916
[TBL] [Abstract][Full Text] [Related]
20. Correlation of microvascular abnormalities and endothelial dysfunction in Type-1 Diabetes Mellitus (T1DM): a real-time intravital microscopy study.
Cheung AT; Tomic MM; Chen PC; Miguelino E; Li CS; Devaraj S
Clin Hemorheol Microcirc; 2009; 42(4):285-95. PubMed ID: 19628894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
